Background and Purpose: The guidelines set forth by the American Physical Therapy
Chapter I Introduction: Literature Review
When deciding whether or not it is safe to work with a patient, a review of lab values is performed to rule out any critical values that may caution or contraindicate mobilization of a critically ill patient. According to the guidelines put together by the acute care section of the American Physical Therapy Association (APTA) for hematological blood values in particular, these values include: normal white blood cell (WBC) count 4,500-11,000/mm 3 in adult males and females, normal platelet count of 150,000-350,000/microL in adult males and females, and normal hemoglobin (Hgb) 14.4-16.6 g/dL in adult males and 12.2-14.7 g/dL in adult females. 1 Within the article that outlines these normal values it is suggested that therapists do not proceed with exercise if WBC count is less than 5,000/mm 3 and is accompanied by a fever, if Hgb is less than 8 g/dL, or if platelets are less than 20,000/microL. 1 These guidelines are ambiguous when it comes to pediatric clients. Pediatric values were not specified in any APTA acute care document, however it was noted that they will vary from birth to 15 years old. An online pediatric care resource outlines that normal WBC count in children ranges from 5,500-15,500/mm 3 for those two to five years of age, 5,000-14,500/mm 3 for those five to eight years, 4,500-13,500/mm 3 for those nine to twelve years of age, and 4,500-13,000/mm 3 in those 13 to 18 years of age. 2 Platelets should range from 150,000-550,000/mm 3 , and hemoglobin should be within 11.5 to 15.5
(g/dL). 2 Children's Hospitals and Clinics of Minnesota, the site at which this particular study was conducted, follow these guidelines for WBC count and hemoglobin, with the exception of 13-16 g/dL as normal hemoglobin for males and 12-16 g/dL as normal for females in the 13-18 year age range. Normal platelets for a child of any age at Children's
Hospital of Minnesota range from 250,000-450,000/mm. 3 Although the guidelines have been in place for many years, evidence for their use is lacking. In fact, no randomized controlled trials were used to establish these normative values. The lab value guidelines given for adults were compiled by a task force of the Acute Care section of the national APTA. They used several acute care textbooks for physical therapists, guides on the interpretation of laboratory tests and critical lab values, and lab value reference books to determine their guidelines. 3 Examining statistics however, may provide further explanation of how these normal values came into existence.
Erstad 4 notes that "normal" lab values are determined by whether the value falls within a normal, bell-shaped curve. He notes that there are people outside of two standard deviations from the mean of a lab value who are still considered healthy individuals. He cautions, along with authors from several other articles, that laboratory values should not be examined in isolation. 1, 4, 5, 6, 7 People have died with "normal" lab values, and people have lived perfectly normal lives with "abnormal" lab values. In addition lab values considered "abnormal" may be "normal" for a particular patient. patients to therapy, rather than follow published guidelines." Thus, there is a consensus among the articles reviewed that laboratory values should not stand alone in determining whether or not to mobilize a patient, but instead many other factors should also be considered. 5, 6, 7 Stiller et al. 6, 7 suggests many ways therapists may decide if a patient is safe to be mobilized, including objective and subjective factors. Objective factors include heart rate (HR), blood pressure (BP), rate pressure product (RPP), cardiac status, oxygenation, respiratory pattern, presence of mechanical ventilation, hemoglobin, platelet count, white blood cell count, fever, and blood glucose level. Each of these disorders has different implications for therapy when initiating mobilization of the critically ill patient.
Children with cancer, specifically leukemia or lymphoma (two of the most common types), have an increased risk of developing low hemoglobin. This is in part due to the destruction of red blood cells when these diseases cause the immune system to produce anti-bodies that clump red blood cells together. These clumps of red blood cells are then recognized by the body as foreign and are destroyed. 8 These and other pediatric cancers also often attack the child's bone marrow where red blood cells are made and replace it with fibrotic tissue, or radiation destroys bone marrow stem cells. 8 Chemotherapy drugs also can lower the amount of healthy blood cells, as these drugs are cytotoxic and not specific to only the tumor cells. 8 Hemoglobin is the predominant oxygen-carrying protein within red blood cells.
A low red blood cell count due to a change in the quantity or quality of red blood cells and thus a decrease in the oxygen carrying capacity of the blood is defined as anemia. 8 Therefore, low levels of hemoglobin correspond with a decreased amount of oxygen available to the tissues of the body and often result in anemia.
Exercising a patient with anemia places increased oxygen demands on the body and causes the heart rate to increase. An increase in heart rate can lead to tachycardia, with accompanying fatigue, generalized weakness, loss of stamina, and shortness of breath. 8 Tachycardia can lead to dysrhythmias, which rarely but sometimes can lead to sudden cardiac arrest. 8 One study by Unverferth et al. found an increase in cardiac dysrhythmias recorded on a Holter monitor for patients with cancer who exerted themselves two to six hours following chemotherapy. 9 This study recommended patients undergoing chemotherapy do not exercise within two to six hours following treatment.
One way to determine whether or not a patient has anemia and the severity of anemia is to examine hemoglobin values. Exercise is contraindicated if Hgb is below 8 g/dL. Light exercise is permitted if Hgb ranges from 8-10 g/dL, and Hgb >10 allows for the patient to attempt resistive exercise according to APTA guidelines. 1 Leukocytosis is the presence of high levels of white blood cells (> 11,000/mm 3 ), indicating likely presence of infection or fever. 1, 5, 6 Acute infections and fever often place greater oxygen demands on the body, and therefore, it is important to carefully monitor oxygen saturation levels, respiratory rate, and rate of perceived exertion during therapy.
Leucopenia is the result of an abnormally low WBC count (< 5,000/mm 3 ), often due to the toxic effect chemotherapy drugs have on these cells. A patient with a low white blood cell count may be at an increased risk for infection and fevers, leading to increased oxygen demands on the body; thus requiring the same precautions as above. 7, 8 According to the APTA guidelines, if the WBC count is less than 5,000/mm 3 Therefore, it is important to weigh the possible risks and benefits of exercising a critically ill patient with abnormal blood values. There is a large body of research that has come out in the past two decades which highlights the benefits of exercise for critically ill patients, including our area of interest, patients with cancer.
To date medical professionals continue to debate the possible positive or negative effects exercise has on patients diagnosed with cancer. 14 As mentioned above, it has been theorized that vigorous exercise may be harmful for patients with cancer; however, no literature supports this notion. In a review of literature regarding early exercise therapies for patients with a cancer diagnosis, 16 of out 18 intervention studies and five out of six descriptive studies documented statistically significant results for various quality of life outcome measures. Four meta-analyses and two systemic reviews on the effects of exercise and aerobic capacity, fatigue, and quality of life in patients with cancer were also found. 19 The meta-analyses and systemic reviews on exercise and patients with cancer revealed 12 studies on exercise capacity, 14 on fatigue, and 19 studies regarding the physical quality of life. Nine randomized control trials looked at the effects of exercise training on muscle strength. A large amount of evidence from these studies supports the positive effects of exercise on physiological outcomes during and after cancer treatments. 19 We were unable to find any studies examining the effects of exercise on children with cancer specifically, yet there are many studies of adult cancer populations that show exercise is beneficial, and therefore is likely beneficial in pediatric populations as well.
In accordance with the evidence that shows physical activity to have a positive impact on function, quality of life, and improving psychosocial well-being in patients with cancer undergoing treatment, the studies also revealed that increased physical activity after a cancer diagnosis reduces the risk of cancer reoccurrence and mortality. 19 The literature has consistently shown that physical exercise following a cancer diagnosis improves quality of life. 16 Many of the physical and functional deficits as a result of cancer and its treatment are impacted by therapeutic interventions including exercise. 16, 19 The literature also shows that exercise during and/or following cancer treatments prevents decline and can improve cardio-respiratory function, body composition, immune function, strength and flexibility, body image, self-esteem, and mood. Exercise can also decrease the number and severity of side effects, decreasing duration of hospitalization, and improving the likelihood for completion of chemotherapy treatment. Similar to findings by vanWeert et al. 19 the psychosocial benefits of exercise in patients with cancer include better adjustment to illness, reduction of stress, and decreased rates of depression and anxiety. 20 Fatigue is one of the most common symptoms experienced after high dose chemotherapy, occurring in 70-90% of patients with cancer. 11, 13 Patients describe fatigue as one of the most difficult symptoms to deal with during chemotherapy treatments, even more distressing than pain, nausea, or vomiting. The fatigue experienced is typically thought to be due to cancer related anemia from decreased hemoglobin levels as a result of chemotherpay. 11, 13 As previously mentioned, when a patient is experiencing anemia inadequate amounts of oxygen are being delivered to peripheral tissues. This in turn can lead to breathlessness, tiredness, and extreme fatigue. Other disadvantages of anemia include the need for blood transfusions, diminished energy, lethargy, sexual dysfunction, impaired concentration, impaired memory, and a decline in intellectual ability. This can lead to decrease in a patient's quality of life and reduce the motivation and desire to participate in exercise. 12 The National Cancer Institute defines mild anemia as hemoglobin levels of 10-11 g/dL. Moderate anemia is defined to be hemoglobin levels between 8-9.9 g/dL, and severe anemia as 6.5-7.9 g/dL. 11 Mild-moderate anemia, although important to note, rarely has a negative impact on a patient's mortality, but has been associated with decreased quality of life and functional status.
As recommended by the APTA, 1 patients with hemoglobin levels between 8-10 g/dL are permitted to participate in light exercise. As physical therapists, this is an ideal time to help improve the quality of life and function of patients receiving chemotherapy and experiencing anemia. Evidence has shown that sedentary patients with breast cancer who have a reduced exercise tolerance report higher degrees of fatigue during chemotherapy treatments when compared to more active, physically fit patients. 13 Exercise offers the strongest evidence for relieving cancer related fatigue. 2 There have been 11 published reports by four different research groups testing the impact exercise has on fatigue during high dose chemotherapy. Two additional studies have looked at the effects of exercise on patients after treatment has been completed. All 13 studies indicate significantly lower levels of fatigue in patients who exercised compared to sedentary controls. 13 Additional evidence has found physically active patients with cancer to have lower resting heart rates, lower blood pressure, more energy, increased muscle strength, and improved restful sleep. Many patients undergoing high dose chemotherapy experience feelings of depression, stress, and anxiety. 20 Using exercise as part of rehab can help improve some of the negative psychosocial aspects often accompanying a cancer diagnosis. Although the benefits of exercise in patients with cancer related fatigue have been shown to be consistent across studies, the studies are limited in number of participants, methodology, and often only include women with breast cancer. 13 The research shows that exercise can improve function, quality of life, and decrease fatigue in individuals with a cancer diagnosis. Exercise has also been found to be safe and improve function in patients with cancer who are critically ill with low blood count values.
Current research regarding decisions on when to mobilize patients in the intensive care unit (ICU) is limited. Mobility interventions for patients in the ICU have not received much attention. Despite the knowledge that exercise is beneficial for decreasing the effects of immobility, and that exercise helps patients return to previous level of functioning, the exact manner and guidelines regarding when to administer rehab treatment or safely administer mobility maneuvers to critically ill patients is not well understood. 6 Research shows improvement in mood, coordination, muscle strength, balance, and work tolerance when critically ill patients receive mobility therapy. 6 Several publications have shown a benefit to early exercise therapies for inpatient populations. 18 Inpatient rehab programs have been shown to benefit exercise capacity, lipid profiles, weight changes, autonomic function, subsequent hospitalization costs, and cardiovascular morbidity and mortality. 25, 19 Inpatients receiving early rehab therapy reported a greater than 50% reduction in depressive symptoms, and also demonstrated better function in activities of daily living (ADLs) after only one month.
Other existing views advise that exercise should only be initiated at the point of complete remission from cancer. 17 Although valuable to acknowledge prevailing advice for patients to rest and avoid intense exercise, this should not outweigh the risks of deconditioning and immobilization. A pilot study by Baker et al. 18 showed that 31 critically ill patients who took part in 69 rehab sessions were mobilized without any deterioration in their health status. Patients were deemed suitable for therapy based on guidelines set by Stiller et al. 6 These guidelines for mobilizing critically ill patients recommend that hemoglobin values be stable and >7g/dL, platelet counts stable and >20,000/microL and white blood cell counts between 4,300-10,800/mm 3 . If any blood value is not within these guidelines, appropriateness of mobilization should be discussed with another physical therapist or other medical professionals before deferment. 7, 22 Few research studies measure blood values during exercise interventions for patients with cancer. The research is even more limited when looking at studies that exercised patients with very low blood counts. We did not find any study that exercised patients with hemoglobin, platelets, or white blood cell counts much below recommended guidelines as set by the APTA. A study by Elter et al. 17 looked at the effects of aerobic training on patients with a cancer diagnosis undergoing high dose chemotherapy. The aerobic exercise consisted of three weekly bike ergometer trainings of 15-30 minutes at sub-maximal intensity. The researchers monitored blood values and set guidelines as for when to discontinue treatment. When patients' platelets were >20,000/microL without any sign of bleeding, they were allowed to proceed with the program but were under special precautions that blood pressure not exceed 170/100. Patients' whose platelets reached <10,000/microL or hemoglobin levels <8g/dL necessitated a blood or platelet transfusion prior to continuation of aerobic training. By the end of the study, all trained subjects performed better on the final test. Sub-maximal endurance capacity also showed significant improvements for the training group during the period of hospitalization.
Throughout the study, median platelet count was 27,000/microL with a minimal count of 8,000/microL. Hemoglobin values on average were 9.2g/dL with minimal blood values reaching 7.7g/dL.
Patients participating in aerobic exercise training were found to be more likely to complete the full intended number of chemotherapeutic treatments as compared to untrained patients. 17 The researchers in this study did not use previously set blood value guidelines for the continuation of physical activity. Instead they only judged patients' ability to participate in exercise based on clinical signs of bleeding. None of the patients in the study with platelet counts <10,000/microL or hemoglobin values <8g/dL suffered bleeding or adverse reactions to exercise. Patients with severe active infection were not allowed to participate in exercise training. This study illustrated the positive effects exercise has on patients with cancer undergoing high dose chemotherapy. It also showed that for patients with cytopenia, aerobic exercise was safe and did not cause increase in bleeding. 17 Dimeo et al. 21 Stiller et al. 22 also looked at the effects of mobilizing critically ill patients with low blood values. Patients' baseline hemoglobin concentration had a mean value of 9.1±1.0g/dL and a range of 7-15.8g/dL. Baseline platelet values had a mean value of 301,000/microL with a range of 42,000-742,000/microL. White blood cell counts ranged from 4,400-20,100/mm 3 with a mean baseline value of 10,500/mm 3 . In two of 69 sessions for mobilization, patients reported feeling dizzy but did not require any direct medical intervention, nor did it limit the treatment session. No change in the severity or frequency of cardiac arrhythmias was noted during mobilizations. 22 In three of 69 occasions, a deterioration in patients' condition required intervention. All three occasions were due to a fall in SpO 2 . Although there was a low incidence of problems during the treatment mobilizations a comprehensive screening process was used to select appropriate patients for mobilization. The guidelines set by Stiller et al. 13 were used as parameters for mobilization. These included hemoglobin values stable and >7g/dL, platelet counts stable and >20,000/microL and white blood cell counts between 4,300-10,800/mm 3 . The low incidence of adverse reactions in this study suggests that guidelines by Stiller et al. 13 and utilizing clinical judgment to assist in deciding appropriateness of critically ill patients for mobilization is safe.
In another study, 20 patients with cancer undergoing bone marrow transplantation participated in a rehab program. The program consisted of treadmill walking according to an interval training protocol for six weeks. Each treatment session was approximately 30 minutes at an intensity 80% of heart rate maximum. 23 Inclusion criteria for the study included sustained platelet counts >20,000/microL, absolute neutrophil count of 1x10 
Chapter II Methods
For this study a retrospective chart review was performed. The subjects were a sample of 73 consecutive children diagnosed with a non-CNS cancer. The children 
Analysis/Results
Once the data was gathered, a Chi-square analysis was used to look for a correlation between critical incidents and chronically low hemoglobin, platelets, and white blood cells. For cases where Chi-square cells were <5, a Fisher exact test of significance was used. Risk ratio was also calculated in order to determine the relative risk of a critical incident following physical therapy intervention when subjects' blood values were low as compared to subjects with normal blood values.
The retrospective chart review included 201 physical therapy treatment sessions for a total of 73 patients. No more than four physical therapy sessions per child were analyzed with a mean number of 2.8 visits per child. The mean age was 9.5 years old and ranged from 3-18 years. The three most common cancer diagnoses were leukemia (60%), solid tumors (32%), and lymphoma (8%). Forty-five percent of the subjects were male and 55% were female. Approximately 14% of the subjects had had either a red blood cell or platelet transfusion in the past week. Fifteen percent of the patients were being seen for inpatient physical therapy, whereas 85.5% were seen in an outpatient setting.
The mean blood values for hemoglobin, platelets, and white blood cells taken within 24 hours of a patient's physical therapy treatment session were found ( Table 1 ).
The mean hemoglobin for this patient population was found to be 10.5 g/dL. The mean platelet value was 226.6 x10 3 /microL, and the mean white blood cell value was 3.5 x10 3 /mm 3 . According to the age adjusted blood count reference values from Children's Hospitals and Clinics of Minnesota, the percentages of subjects whose values were normal versus abnormal were calculated (Table 1) .
Abnormal hemoglobin and platelet values were divided further according to APTA guidelines for exercise. Ten percent of the patients had hemoglobin values of <8 and 5.5% of the subjects had platelet values <20,000 indicating no exercise permitted. It is important to note the low percentages of patients with normal blood values and the very high percentages of patients with abnormal blood values in this pediatric oncology population. More than two thirds of the pediatric oncology population receiving physical therapy at Children's Hospitals and Clinics of Minnesota had abnormal blood values.
Very few patients had such low blood values that no exercise would have been recommended by the APTA guidelines.
Of the 201 patient charts reviewed, there were a total of thirteen critical incidents that occurred within two days following a physical therapy treatment session. Table 1 .
Mean blood values for the examined pediatric oncology population and percentages of normal and abnormal blood lab values (n=201) Approximately 6.5% of the patient population actually had a critical incident, as defined by the research study. The thirteen events included seven events of tachycardia, three subjective complaints of pain, two fevers, and one fall that occurred during the physical therapy session. There were no episodes of arrhythmia, syncope, hypotension, oxygen desaturation less than 90%, shortness of breath, major bleeds, or skin integrity issues.
Having a critical incident was very rare, and those that did occur were not severe enough to institute major medical attention. Seventy-six percent had no documented adverse symptoms during their physical therapy session. The remaining 24% had complaints of fatigue, pain, nausea, and/or shortness of breath. Physical therapy was modified accordingly in 5.5% of patient cases. These symptoms were not defined as critical incidents.
There was very little difference in the percentages of patients experiencing critical events when blood values were normal as compared to abnormal blood values (Figure 1 ). 
Distribution of Critical Events for Normal and Abnormal Hemoglobin Values
The distribution of critical events for normal and abnormal platelet values found that 8% of patients whose platelets were normal had a critical event (Figure 4 ). For patients with abnormal platelets, yet >50,000, 7% had a critical event. For values 20,000-50,000, zero out of the four participants had a critical event. For patients with platelets <20,000, indicating no exercise permitted, zero of the seven had a critical event. No significant differences were found in the way confidence intervals were distributed for platelets (X 2 =0.974, p= 0.808) (Figure 4 ).
For patients with low platelet blood values, it is recommended that physical therapy avoid activities such as stretching due to the decreased ability of the patient's blood to clot. When patients' platelet values were abnormally low, there was no significant difference found in the distribution of critical incidents in patients with Table 2) . Four percent of patients with abnormal platelets and were stretched had a critical event, whereas 8% of patients without stretching during physical therapy had a critical event. Another common concern is for patients with low hemoglobin values performing endurance exercises. It is recommended that physical therapy avoid endurance exercises when patients' hemoglobin values are abnormally low due to increased risk of fatigue, tachycardia, and the increased oxygen demands placed on the body's tissues. There was no significant difference found in the distribution of critical incidents in patients with abnormally low hemoglobin when endurance exercises were done versus no endurance exercises (X 2 =0.066, p= 1.00) ( Table 3) . Eight percent of patients with abnormal hemoglobin values who performed endurance exercises had a critical event, whereas 9% of patients without endurance exercises during physical therapy had a critical event. 
Chapter IV Discussion
Chi-Square analyses indicated no significant correlation between critical incidents and chronically low hemoglobin, low platelets, or low white blood cells. High percentages of patients in the pediatric oncology population have chronically low blood values. According to Stiller et al. 6 chronically low blood values for a particular patient should be treated differently than an acute change. If a patient has been living stably with chronically abnormal lab values it has been the practice of many physicians to allow physical activity in order to prevent the deleterious results of bed rest and inactivity.
These deleterious effects include: muscle weakness, decreased muscle endurance, negative nitrogen balance, pneumonia, thrombosis, kidney stones, increased diuresis, orthostatic hypotension, cardiovascular deconditioning, skin breakdown, depression, fatigue, and decreased quality of life. 10 Therefore it is important to weigh the possible risks and benefits of exercising a patient with abnormal blood values. In the current study, physical therapy was found to be very safe when using symptom based guidelines for activity in children being treated for cancer with a very low percentage of critical events.
Of the thirteen critical incidents that did occur, all events were minor with approximately 50% having symptoms of tachycardia. Tachycardia happens to be a common symptom of low hemoglobin, and its occurrence is somewhat expected and does not merit discontinuing physical therapy. No major events such as heart arrhythmias, syncope, hypotension, or major bleeds occurred in any of the patients receiving physical therapy treatment.
There was also no increased risk of critical events in children with low platelets or low white blood cells when compared to normal blood values with risk ratios 0.79 and 0.64 respectively. An increased risk ratio of 4.3 was noted for critical incidents in subjects with low hemoglobin as compared to normal hemoglobin values. Despite an increased risk ratio, a confidence interval of 0.58-32.30 indicates patients had a decreased risk of event, no additional risk, or an increased risk of critical event. We cannot be confident that the risk ratio for hemoglobin is significant. A power analysis for hemoglobin indicated insufficient number of subjects to be confident in the finding of no relationship.
A study by Dimeo et al. 14 In the current study, there was also no significant relationship between critical incidents and specific sub-populations of patients such as type of cancer, age, or type of physical therapy exercise. When patients' platelet values were abnormally low, there was no significant difference found in the distribution of critical incidents in patients with stretching versus no stretching. There was no significant difference found in the distribution of critical incidents in patients with abnormally low hemoglobin when endurance exercises were done versus no endurance exercises.
These results of the current study suggest the use of a symptom-based approach in determining appropriateness for physical therapy may be utilized in pediatric populations experiencing chronically low blood values. An additional screening process for determining patients appropriate for physical therapy has been proposed by Stiller et. al. 13 The guidelines recommend that hemoglobin values be stable and >7g/dL, platelet counts stable and >20,000/microL and white blood cell counts between 4,300-10,800/mm 3 . If any blood value is not within these guidelines, appropriateness of mobilization should be discussed with another physical therapist or medical professional before deferment.
Therapists may be able to decide if a patient is safe for physical therapy based on additional objective and/or subjective factors. Objective factors include heart rate, blood pressure, cardiac status, oxygenation, respiratory pattern, or blood glucose levels.
Subjective symptoms such as the patient's facial expression, emotional state, pain, anxiety, pallor, rate of perceived exertion, and/or diaphoresis may be used for determining patients' appropriateness for physical activity. These guidelines in conjunction with clinical judgment, experience, and current APTA hematological guidelines may be utilized in populations experiencing chronically low blood values.
Limitations of this study include the small sample size. Of the 201 total charts reviewed, there were only 13 critical incidents identified. Having so few critical incidents makes it difficult to find statistically significant correlations. Only 9.8% of the patients receiving physical therapy had hemoglobin values <8 and only 5.5% of patients had platelets <20,000. Conducting a larger study with more participants may result in more subjects with extreme low blood values allowing researchers to investigate the relationship between physical therapy and critical incidents. Also, if we are suggesting a symptom-based approach to determining level of activity during physical therapy, it would be interesting to note the types of modifications physical therapists made to treatment sessions when patients' blood values were low. Although efforts were made to record any changes to physical therapy treatment sessions, all modifications may not have been fully documented limiting our ability to know what specific changes actually minimized the occurrence of critical events. In addition, it is possible we may not have had access to all emergency medical files from outside hospitals. Although one can expect a phone call would be made from the outside hospital and placed in the child's medical record, we cannot be completely confident we were able to record all critical incidents.
Chapter V Conclusion
The results of this study support our original hypothesis. There was no difference in the amount of critical incidents occurring within two days after physical therapy in pediatric oncology patients with chronically low blood values versus normal blood values. Physical therapy was found to be safe for children experiencing chronically low blood values from chemotherapy treatment when the therapist used symptoms as a guideline for treatment parameters. Additionally, when analyzed, there were no subpopulations of patients found to be at an increased risk of critical events. The evidence suggests a symptom-based approach in determining appropriateness for physical therapy may be utilized in populations experiencing chronically low blood values. Future studies with larger samples sizes are needed to ascertain whether these findings are consistent and statistically significant.
